enVVeno Medical Corporation
NVNO
$10.33
$0.333.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.61% | -24.67% | -21.81% | 22.94% | -2.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.01% | -35.09% | -16.14% | 12.27% | -9.98% |
| Operating Income | 18.01% | 35.09% | 16.14% | -12.27% | 9.98% |
| Income Before Tax | 14.52% | 40.02% | 19.55% | -35.07% | 9.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.52% | 40.02% | 19.55% | -35.07% | 9.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.52% | 40.02% | 19.55% | -35.07% | 9.80% |
| EBIT | 18.01% | 35.09% | 16.14% | -12.27% | 9.98% |
| EBITDA | 17.97% | 35.17% | 16.06% | -12.70% | 9.80% |
| EPS Basic | 24.06% | 43.33% | 35.87% | -6.63% | 28.77% |
| Normalized Basic EPS | 24.20% | 38.63% | 34.41% | 13.03% | 31.32% |
| EPS Diluted | 24.06% | 43.33% | 35.87% | -6.63% | 28.77% |
| Normalized Diluted EPS | 24.20% | 38.63% | 34.41% | 13.03% | 31.32% |
| Average Basic Shares Outstanding | 12.56% | 5.83% | 25.44% | 26.66% | 26.63% |
| Average Diluted Shares Outstanding | 12.56% | 5.83% | 25.44% | 26.66% | 26.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |